CLASS II ONGOING Device recall · Reported 14 Feb 2024 · FDA Enforcement Report

RX Series Copper (Cu) Assay recalled by Randox Laboratories

Randox Laboratories is recalling RX Series Copper (Cu) Assay, distributed nationwide in the US. The recall was initiated on 29 Nov 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalogue Number/GTIN: CU2340 05055273201949; Lot/batch: 592278, 610661, 610669, 629021, 647201, 657944;
Quantity recalled3,053 kits (2 US, 3,051 OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0992-2024
FDA event ID
93775
Recalling firm
Randox Laboratories, Crumlin (North)
Classification
Class II
Status
Ongoing
Recall initiated
29 Nov 2023
FDA classified
6 Feb 2024
Reported
14 Feb 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

29 Nov 2023Recall initiated by company
6 Feb 2024Classified by FDA+69 days
14 Feb 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

RX Series Copper (Cu) Assay Ref. Number CU2340

Where it was distributed

US Nationwide distribution in the states of SC and OK.

Nationwide OklahomaSouth Carolina

Questions about this recall

Why was it recalled?

Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.

Which lots are affected?

Catalogue Number/GTIN: CU2340 05055273201949; Lot/batch: 592278, 610661, 610669, 629021, 647201, 657944;

Where was it sold?

US Nationwide distribution in the states of SC and OK.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Randox Laboratories

All 98

Other Test Kits & Diagnostics recalls

All 2,663